I think the majority of sales will be booked in the current financial year but with the projected EBITDA of 15M to 18M the margins must be low
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025